1.  Evaluation of systemic administration of Boswellia papyrifera extracts on spatial memory retention in male rats Author(s): Mahmoudi A, Hosseini-Sharifabad A, Monsef-Esfahani HR, et al. Source: JOURNAL OF NATURAL MEDICINES Volume: 65 Issue: 3-4 Pages: 519-525 Published: JUL 2011
2. Protein kinase C stabilizes X-linked inhibitor of apoptosis protein (XIAP) through phosphorylation at Ser(87) to suppress apoptotic cell death Author(s): Kato Kiyoko; Tanaka Toshihisa; Sadik Golam; et al. Source: PSYCHOGERIATRICS Volume: 11 Issue: 2 Pages: 90-97 DOI: 10.1111/j.1479-8301.2011.00355.x Published: JUN 2011
3. PKC epsilon Activation Prevents Synaptic Loss, A beta Elevation, and Cognitive Deficits in Alzheimer's Disease Transgenic Mice Author(s): Hongpaisan J, Sun MK, Alkon DL Source: JOURNAL OF NEUROSCIENCE Volume: 31 Issue: 2 Pages: 630-643 Published: JAN 12 2011
4. Natural products as a source of Alzheimer's drug leads Author(s): Williams P, Sorribas A, Howes MJR Source: NATURAL PRODUCT REPORTS Volume: 28 Issue: 1 Pages: 48-77 Published: 2011
5. Identification of Novel Small Molecule Activators of Nuclear Factor-kappa B With Neuroprotective Action Via High-Throughput Screening Author(s): Manuvakhova MS, Johnson GG, White MC, et al. Source: JOURNAL OF NEUROSCIENCE RESEARCH Volume: 89 Issue: 1 Pages: 58-72 Published: JAN 2011
6. Pharmacology of protein kinase C activators: Cognition-enhancing and antidementic therapeutics Author(s): Sun MK, Alkon DL Source: PHARMACOLOGY & THERAPEUTICS Volume: 127 Issue: 1 Pages: 66-77 Published: JUL 2010
7. Calcium Induces Expression of Cytoplasmic Gelsolin in SH-SY5Y and HEK-293 Cells Author(s): Ji LN, Chauhan A, Chauhan V Source: NEUROCHEMICAL RESEARCH Volume: 35 Issue: 7 Pages: 1075-1082 Published: JUL 2010
8. Early diagnostic accuracy and pathophysiologic relevance of an autopsy-confirmed Alzheimer's disease peripheral biomarker Author(s): Khan TK, Alkon DL Source: NEUROBIOLOGY OF AGING Volume: 31 Issue: 6 Pages: 889-900 Published: JUN 2010
9. Upregulation of Cytoplasmic Gelsolin, an Amyloid-beta-Binding Protein, Under Oxidative Stress Conditions: Involvement of Protein Kinase C Author(s): Ji LN, Chauhan A, Chauhan V Source: JOURNAL OF ALZHEIMERS DISEASE Volume: 19 Issue: 3 Pages: 829-838 Published: 2010
10. Protein kinase C as a peripheral biomarker for Alzheimer's disease Author(s): de Barry J, Liegeois CM, Janoshazi A Source: EXPERIMENTAL GERONTOLOGY Volume: 45 Issue: 1 Special Issue: Sp. Iss. SI Pages: 64-69 Published: JAN 2010
11. Protein Kinase C Activators as Synaptogenic and Memory Therapeutics Author(s): Sun MK, Alkon DL Source: ARCHIV DER PHARMAZIE Volume: 342 Issue: 12 Pages: 689-698 Published: DEC 2009
12. Protein Kinase C Involvement in the Acetylcholine Release Reduction Induced by Amyloid-beta(25-35) Aggregates on Neuromuscular Synapses Author(s): Tomas M, Garcia N, Santafe MM, et al. Source: JOURNAL OF ALZHEIMERS DISEASE Volume: 18 Issue: 4 Pages: 877-884
13. A cellular model of Alzheimer's disease therapeutic efficacy: PKC activation reverses A beta-induced biomarker abnormality on cultured fibroblasts Author(s): Khan TK, Nelson TJ, Verma VA, et al. Source: NEUROBIOLOGY OF DISEASE Volume: 34 Issue: 2 Pages: 332-339 Published: MAY 2009
14. Protein kinase C mediates amyloid beta-protein fragment 31-35-induced suppression of hippocampal late-phase long-term potentiation in vivo Author(s): Zhang JF, Qi JS, Qiao JT Source: NEUROBIOLOGY OF LEARNING AND MEMORY Volume: 91 Issue: 3 Pages: 226-234 Published: MAR 2009
15. Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair Author(s): Nelson TJ, Sun MK, Hongpaisan J, et al. Source: EUROPEAN JOURNAL OF PHARMACOLOGY Volume: 585 Issue: 1 Pages: 76-87 Published: MAY 6 2008
16. Synergistic effects of chronic bryostatin-1 and alpha-tocopherol on spatial learning and memory in rats Author(s): Sun MK, Alkon DL Source: EUROPEAN JOURNAL OF PHARMACOLOGY Volume: 584 Issue: 2-3 Pages: 328-337 Published: APR 28 2008
17. Nelson TJ, Alkon DL Protection against beta-amyloid-induced apoptosis by peptides interacting with beta-amyloid JOURNAL OF BIOLOGICAL CHEMISTRY 282 (43): 31238-31249 OCT 26 2007
18. Alkon DL, Sun MK, Nelson TJ PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease TRENDS IN PHARMACOLOGICAL SCIENCES 28 (2): 51-60 FEB 2007
19. Khan TK, Alkon DL An internally controlled peripheral biomarker for Alzheimer's disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 103 (35): 13203-13207 AUG 29 2006
20. Sun MK, Alkon DL Bryostatin-1: Pharmacology and therapeutic potential as a CNS drug CNS DRUG REVIEWS 12 (1): 1-8 SPR 2006
21. Kuzirian AM, Epstein HT, Gagliardi CJ, et al. Bryostatin enhancement of memory in Hermissenda BIOLOGICAL BULLETIN 210 (3): 201-214 JUN 2006
22. Murphy EJ, Huang HM, Cowburn RF, et al. Phospholipid mass is increased in fibroblasts bearing the Swedish amyloid precursor mutation BRAIN RESEARCH BULLETIN 69 (1): 79-85 MAR 15 2006
23. Li X, Lu F, Tian Q, et al. Activation of glycogen synthase kinase-3 induces Alzheimer-like tau hyperphosphorylation in rat hippocampus slices in culture J NEURAL TRANSM 113 (1): 93-102 JAN 2006
24. Misiti F, Sampaolese B, Pezzotti M, et al. A beta(31-35) peptide induce apoptosis in PC 12 cells: Contrast with A beta(25-35) peptide and examination of underlying mechanisms NEUROCHEM INT 46 (7): 575-583 JUN 2005
25. Sun MK, Alkon DL Dual effects of bryostatin-1 on spatial memory and depression EUR J PHARMACOL 512 (1): 43-51 APR 4 2005
26. Morgan C, Colombres M, Nunez MT, et al. Structure and function of amyloid in Alzheimer's disease PROG NEUROBIOL 74 (6): 323-349 DEC 2004
27. Sun MK, Alkon DL Cerebral hypoperfusion and amyloid-induced synergistic impairment of hippocampal CA1 synaptic efficacy and spatial memory in young adult rats J ALZHEIMERS DIS 6 (4): 355-366 AUG 2004
28. Etcheberrigaray R, Tan M, Dewachter I, et al. Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice P NATL ACAD SCI USA 101 (30): 11141-11146 JUL 27 2004
29. Lee W, Boo JH, Jung MW, et al. Amyloid beta peptide directly inhibits PKC activation MOL CELL NEUROSCI 26 (2): 222-231 JUN 2004
30. Sponne I, Fifre A, Kriem B, et al. Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of the amyloid-beta peptide FASEB J 18 (3): - MAR 2004
31. Singh AB, Harris RC Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells J BIOL CHEM 279 (5): 3543-3552 JAN 30 2004
32. Matsumoto S, Shamloo M, Matsumoto E, et al. Protein kinase C-gamma and calcium/calmodulin-dependent protein kinase II-alpha are persistently translocated to cell membranes of the rat brain during and after middle cerebral artery occlusion J CEREBR BLOOD F MET 24 (1): 54-61 JAN 2004
33. Liu SJ, Zhang AH, Li HL, et al. Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory J NEUROCHEM 87 (6): 1333-1344 DEC 2003
34. Cedazo-Minguez A, Popescu BO, Blanco-Millan JM, et al. Apolipoprotein E and beta-amyloid (1-42) regulation of glycogen synthase kinase-3 beta J NEUROCHEM 87 (5): 1152-1164 DEC 2003
35. Jong YJI, Ford SR, Seehra K, et al. Alzheimer's disease skin fibroblasts selectively express a bradykinin signaling pathway mediating tau protein Ser phosphorylation FASEB J 17 (13): U421-+ OCT 2003
36. De Ferrari GV, Chacon MA, Barria MI, et al. Activation of Wnt signaling and behavioral impairments rescues neurodegeneration induced by beta-amyloid fibrils MOL PSYCHIATR 8 (2): 195-208 2003
37. De Ferrari GV, Chacon MA, Barria MI, et al. Activation of Wnt signaling and behavioral impairments rescues neurodegeneration induced by beta-amyloid fibrils MOL PSYCHIATR 8 (2): 195-208 2003
38. Sponne I, Fifre A, Drouet A, et al. Apoptotic neuronal cell death induced by the non-fibrillar amyloid-beta peptide proceeds through an early reactive oxygen species-dependent cytoskeleton perturbation J BIOL CHEM 278 (5): 3437-3445 JAN 31 2003
39. Olariu A, Yamada K, Mamiya T, et al. Memory impairment induced by chronic intracerebroventricular infusion of beta-amyloid (1-40) involves downregulation of protein kinase C BRAIN RES 957 (2): 278-286 DEC 13 2002
40. Zhao WQ, Ravindranath L, Mohamed AS, et al. MAP kinase signaling cascade dysfunction specific to Alzheimer's disease in fibroblasts NEUROBIOL DIS 11 (1): 166-183 OCT 2002
41. Garrido JL, Godoy J, Alvarez A, et al.Protein kinase C inhibits amyloid beta-peptide neurotoxicity by acting on members of the Wnt pathway FASEB J 16 (12): U8-U27 OCT 2002
42. Pakaski M, Balaspiri L, Checler F, et al. Human amyloid-beta causes changes in the levels of endothelial protein kinase C and its alpha isoform in vitro NEUROCHEM INT 41 (6): 409-414 DEC 2002
43. Inestrosa NC, De Ferrari GV, Garrido JL, et al. Wnt signaling involvement in beta-amyloid-dependent neurodegeneration NEUROCHEM INT 41 (5): 341-344 NOV 2002
44. Sun MK, Alkon DL Impairment of hippocampal CA1 heterosynaptic transformation and spatial memory by beta-amyloid(25-35) J NEUROPHYSIOL 87 (5): 2441-2449 MAY 2002
45. Cedazo-Minguez A, Wiehager B, Winblad B, et al. Effects of apolipoprotein E (apoE) isoforms, beta-amyloid (A beta) and apoE/A beta complexes on protein kinase C-alpha (PKC-alpha) translocation and amyloid precursor protein (APP) processing in human SH-SY5Y neuroblastoma cells and fibroblasts
    NEUROCHEM INT 38: (7) 615-625 JUN 2001
46. Rossner S, Mehlhorn G, Schliebs R, et al. Increased neuronal and glial expression of protein kinase C isoforms in neocortex of transgenic Tg2576 mice with amyloid pathology EUR J NEUROSCI 13: (2) 269-278 JAN 2001
47. Kuperstein F, Reiss N, Koudinova N, et al. Biphasic modulation of protein kinase C and enhanced cell toxicity by amyloid beta peptide and anoxia in neuronal cultures J NEUROCHEM 76: (3) 758-767 FEB 2001
48. Fukushima S, Kishimoto S, Takeuchi Y, et al. Preparation and evaluation of o/w type emulsions containing antitumor prostaglandin ADV DRUG DELIVER REV 45: (1) 65-75 DEC 6 2000
49. Tremblay R, Chakravarthy B, Hewitt K, et al. Transient NMDA receptor inactivation provides long-term protection to cultured cortical neurons from a variety of death signals J NEUROSCI 20: (19) 7183-7192 OCT 1 2000
50. De Ferrari GV, Inestrosa NC Wnt signaling function in Alzheimer's disease BRAIN RES REV 33: (1) 1-12 AUG 2000
51. Favit A, Grimaldi M, Alkon DL Prevention of beta-amyloid neurotoxicity by blockade of the ubiquitin-proteasome proteolytic pathway J NEUROCHEM 75: (3) 1258-1263 SEP 2000
52. Murphy EJ, Zhang H, Sorbi S, et al. Phospholipid composition and levels are not altered in fibroblasts bearing presenilin-1 mutations BRAIN RES BULL 52: (3) 207-212 JUN 2000
53. Christner C, Wyrwa R, Marsch S, et al  Synthesis and cytotoxic evaluation of cycloheximide derivatives as potential inhibitors of FKBDP12 with neuroregenerative properties J MED CHEM 42: (18) 3615-3622 SEP 9 1999
54. Pillot T, Drouet B, Queille S, et al. The nonfibrillar amyloid beta-peptide induces apoptotic neuronal cell death: Involvement of its C-terminal fusogenic domain J NEUROCHEM 73: (4) 1626-1634 OCT 1999
55. Ibarreta D, Duchen M, Ma DW, et al.  Benzolactam (BL) enhances sAPP secretion in fibroblasts and in PC12 cells
    NEUROREPORT 10: (5) 1035-1040 APR 6 1999